EcoDrugPlus

Ensembl ID : ENSAOCG00000024144
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSAOCG00000019297
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSAOCG00000023836
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSAOCG00000016231
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSAOCG00000019598
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSAOCG00000022278
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSAOCG00000021874
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSAOCG00000021859
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSAOCG00000002025
Gene Symbol: -
Cross references: -
281 Possible Orthologues:

Ensembl ID : ENSAOCG00000017970
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSAOCG00000017289
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSAOCG00000012825
Gene Symbol: -
Cross references: -
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).